Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,079 total articles
Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions, announced that Interim CEO Eric So will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York on June 4, 2026. The company is advancing proprietary drugs HLP003 and HLP004 for major depressive…
BriaCell Therapeutics Corp. announced positive clinical data from Phase 2 and ongoing Phase 3 studies of its Bria-IMT immunotherapy for heavily pre-treated metastatic breast cancer patients at the 2026 ASCO Annual Meeting. Data demonstrated promising survival rates, good quality of life, and potential predictive biomarkers, supporting continued dev…
New Era Energy & Digital, Inc. announced participation in several major investor and industry conferences in June 2026, highlighting its leadership presence. The company also expects to be added to the Russell 3000 and Russell Microcap Indexes following the annual reconstitution, effective June 29, 2026. This inclusion signals increased visibility …
Edible Garden AG Incorporated has completed a major logistics overhaul in the Metro New York area, shifting from a Direct Store Delivery model to a direct-to-distribution-center and regional hub model. This change is expected to significantly reduce transportation costs and carbon emissions, improving operational efficiency and supporting the compa…
Piedmont Realty Trust announced that it has signed approximately 240,000 square feet of leases in the second quarter so far, with more than 60% representing new tenant leasing and 90% of new leases for previously vacant spaces. This brings the year-to-date leasing volume to approximately 670,000 square feet. The company highlights sustained high de…
IREN Limited has successfully closed a $3.65 billion investment-grade GPU financing facility, the largest publicly rated GPU financing to date, to support its AI Cloud contract with Microsoft. The facility includes a $2.10 billion U.S. private placement and a $1.55 billion delayed draw term loan, funding 96% of the $5.81 billion GPU capital expendi…
Science Applications International Corporation (SAIC) announced its Q1 FY2027 results with revenues of $1.91 billion, a 2% increase including acquisitions, and modest organic growth of 0.5%. The company reported adjusted EBITDA of $222 million, a 41% increase year-over-year, and adjusted diluted EPS of $3.23, up 68%. Cash flow from operations impro…
Invivyd, Inc., a U.S.-based biopharmaceutical company, announced the completion of enrollment in its Phase 3 DECLARATION clinical trial testing VYD2311, an investigational monoclonal antibody administered intramuscularly for the prevention of symptomatic COVID-19. The trial was upsized by approximately 500 subjects to enhance statistical power due …
Jade Biosciences announced positive interim Phase 1 trial results of JADE101, a novel anti-APRIL monoclonal antibody for immunoglobulin A nephropathy (IgAN). Results demonstrated approximately 70% sustained IgA reduction at 12 weeks after a single dose, with potential for every 12-week subcutaneous maintenance dosing. JADE101 showed faster, deeper,…
Monopar Therapeutics presented Phase 2 clinical trial results of ALXN1840 at EASL 2026, demonstrating stabilization of liver disease and significant neurological improvements in treatment-experienced Wilson disease patients. The therapy was well tolerated and improved patients' quality of life, highlighting its potential as a novel treatment option…
Kamada Ltd., a global biopharmaceutical company (NASDAQ: KMDA), announced FDA approval of its new in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) laboratory for measuring rabies-neutralizing antibodies. This state-of-the-art lab in Israel expands Kamada's testing capabilities for its key anti-rabies products KEDRAB® and KAMRAB®, supporting…
Anfield Energy Inc. has successfully completed Phase One surface construction at its Velvet-Wood uranium and vanadium mine in Utah, marking significant progress. The company will now proceed to Phase Two, involving underground development, aiming to resume production by the end of 2026. This advancement aligns with U.S. energy independence goals an…
Axsome Therapeutics is supporting the Headache Alliance’s first annual Headache in the City campaign and raising awareness during Migraine and Headache Awareness Month. The company highlights the significant impact of migraine and shares educational resources, reinforcing its commitment to the migraine community as part of its broader mission to tr…
Kinross Gold Corporation released its comprehensive 2025 Sustainability Report, showcasing progress in health and safety, community investment, environmental management, and energy efficiency. The report underscores the company's leadership in sustainability ratings within the mining sector, increased female workforce representation, substantial ec…
REalloys Inc. (NASDAQ: ALOY) announced its inclusion in the Russell 3000® Index effective June 29, 2026. This inclusion recognizes the company's market capitalization and allows for automatic membership in related Russell indexes, potentially increasing the stock's visibility among institutional investors and passive funds. This milestone is signif…
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., has been ranked No. 15 on TIME's World's Most Impactful Companies 2026 list. This ranking, based on rigorous science-backed methodology, recognizes the company's measurable positive impact across society, health, knowledge, and the environ…
Ollie’s Bargain Outlet has named Jared Shure as Senior Vice President, General Counsel, and Corporate Secretary. Shure brings nearly 20 years of legal and business experience from previous roles at The Children’s Place, Kate Spade, and Tapestry. He will oversee legal, compliance, and corporate governance functions, aiming to support the company’s s…
Fractyl Health, a clinical-stage metabolic therapeutics company, has appointed Mike Zumdahl as Senior Vice President of Market Access and Commercial Strategy. Zumdahl brings extensive experience in health economics and reimbursement, having previously led market access at Inari Medical and contributed to launching the GLP-1 category at Novo Nordisk…
Lantronix Inc. announces the launch of the SLC 9000, an advanced out-of-band console manager integrated with its Percepxion cloud management platform. Designed for AI data centers, hyperscale deployments, military, and industrial facilities, the device offers secure remote access, autonomous provisioning, and cellular failover to minimize downtime …
Syndax Pharmaceuticals announced it will host an R&D Day on July 14, 2026, to showcase its late-stage programs including revumenib and axatilimab targeting cancer and immune-related diseases, along with new early-stage assets. Management and key opinion leaders will present clinical developments and future plans aimed at expanding treatment options…
Weatherford International plc (NASDAQ: WFRD) has entered into a definitive agreement to acquire NCS Multistage Holdings, Inc. (NASDAQ: NCSM). The acquisition aims to expand Weatherford's completions portfolio and deepen its capabilities in the unconventional oil and gas segment. The deal is expected to be accretive to free cash flow per share and d…
Marex Group plc (NASDAQ: MRX), a global financial services platform, has acquired Levmet, a Monaco-based liquidity provider in physical and derivatives markets for metals and energy. The acquisition strengthens Marex’s physical market making operations and expands their capabilities in European power and gas trading, aligning with their strategy to…
Actuate Therapeutics announced positive clinical and biomarker data from Phase 2 studies demonstrating that elraglusib, combined with standard chemotherapy regimens gemcitabine/Abraxane and FOLFIRINOX, significantly improves median overall survival in patients with metastatic pancreatic ductal adenocarcinoma, especially those with specific wild-typ…
Waldencast plc has entered into an agreement to sell its dermatological skincare brand Obagi Medical to Bridgepoint for up to $460 million. The deal will strengthen Waldencast's balance sheet and allow the company to concentrate on expanding its other beauty brand, Milk Makeup. The transaction is expected to close in Q3 2026, with Waldencast planni…
NusaTrip Incorporated disclosed receipt of a delinquency notification from Nasdaq for failing to timely file its 2025 annual and 2026 quarterly reports, potentially risking delisting unless compliance is regained by October 2026. The company is actively working to file the delayed reports to avoid further penalties and maintain its Nasdaq listing.
